Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,231 | 55 | 96.5% |
| Education | $45.04 | 2 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $424.71 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $355.58 | 17 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $164.98 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $123.50 | 5 | $0 (2024) |
| Mylan Specialty L.P. | $50.29 | 3 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $43.20 | 2 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $31.78 | 2 | $0 (2024) |
| Inspire Medical Systems, Inc. | $31.25 | 1 | $0 (2023) |
| GENZYME CORPORATION | $25.93 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $24.34 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.13 | 38 | AstraZeneca Pharmaceuticals LP ($337.45) |
| 2023 | $423.18 | 18 | Harmony Biosciences LLC ($257.24) |
| 2022 | $21.25 | 1 | JAZZ PHARMACEUTICALS INC. ($21.25) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: Narcoplepsy | ||||||
| 12/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: ANTIBIOTIC | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Education | In-kind items and services | $23.32 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Education | In-kind items and services | $21.72 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Narcoplepsy | ||||||
| 10/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ANTIBIOTIC | ||||||
| 09/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: Immunology | ||||||
| 09/03/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Narcoplepsy | ||||||
| 08/30/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.45 | General |
| Category: Narcoplepsy | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Respiratory | ||||||
| 08/20/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/31/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $52.54 | General |
| Category: Respiratory | ||||||
| 07/26/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $28.98 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 312 | 359 | $84,423 | $25,268 |
| 2022 | 5 | 166 | 178 | $55,072 | $12,736 |
| 2021 | 5 | 319 | 344 | $96,948 | $25,033 |
| 2020 | 5 | 171 | 175 | $44,903 | $9,062 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 187 | $43,384 | $13,781 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 80 | $14,800 | $3,519 | 23.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 26 | $8,138 | $2,988 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 43 | 43 | $9,890 | $2,648 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,211 | $2,332 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 44 | 49 | $17,148 | $3,642 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 45 | 48 | $12,240 | $2,521 | 20.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $8,330 | $1,966 | 23.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 14 | $4,727 | $1,490 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $4,335 | $1,133 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 12 | 12 | $4,680 | $1,065 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 18 | 21 | $3,612 | $918.86 | 25.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 68 | 74 | $25,894 | $7,309 | 28.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 81 | 88 | $22,575 | $5,445 | 24.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 28 | $9,632 | $3,296 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 85 | 91 | $15,652 | $3,232 | 20.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 20 | 20 | $9,800 | $2,206 | 22.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 25 | $6,375 | $2,143 | 33.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 18 | 18 | $7,020 | $1,404 | 20.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 90 | 92 | $23,595 | $4,752 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 40 | 42 | $7,307 | $1,454 | 19.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 19 | 19 | $6,536 | $1,438 | 22.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 11 | 11 | $4,290 | $851.50 | 19.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 11 | 11 | $3,175 | $566.35 | 17.8% |
About Harris Smith, PA-C
Harris Smith, PA-C is a Athletic Trainer healthcare provider based in Roanoke Rapids, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/19/2012. The National Provider Identifier (NPI) number assigned to this provider is 1326313719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Harris Smith, PA-C has received a total of $1,276 in payments from pharmaceutical and medical device companies, with $831.13 received in 2024. These payments were reported across 57 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,231).
As a Medicare-enrolled provider, Smith has provided services to 968 Medicare beneficiaries, totaling 1,056 services with total Medicare billing of $72,099. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Athletic Trainer
- Other Specialties Physician Assistant
- Location Roanoke Rapids, NC
- Active Since 03/19/2012
- Last Updated 11/23/2022
- Taxonomy Code 2255A2300X
- Entity Type Individual
- NPI Number 1326313719
Products in Payments
- WAKIX (Drug) $424.71
- AIRSUPRA (Drug) $264.08
- XYWAV (Drug) $164.98
- TRELEGY ELLIPTA (Drug) $123.50
- FASENRA (Biological) $69.78
- YUPELRI (Drug) $50.29
- DUPIXENT (Biological) $50.27
- LUMRYZ (Drug) $43.20
- NUZYRA (Drug) $31.78
- INSPIRE (Device) $31.25
- BREZTRI (Drug) $21.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.